![](/img/cover-not-exists.png)
Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer
Colby L. Eaton, Jason M. Wells, Ingunn Holen, Peter I. Croucher, Freddie C. HamdyVolume:
59
Year:
2004
Language:
english
Pages:
7
DOI:
10.1002/pros.20016
File:
PDF, 110 KB
english, 2004